Top Oversight Dem pushes for White House opioid briefing

Top Oversight Dem pushes for White House opioid briefing
© Moriah Ratner

The top Democrat on the House Oversight and Government Reform Committee is calling for the White House to brief the panel on its efforts to implement recommendations from the president's opioid commission.

Rep. Elijah CummingsElijah Eugene CummingsRep. Cummings: Will Kavanaugh take lie detector test and ask for FBI investigation? Graham to renew call for second special counsel Hillicon Valley: Sanders finds perfect target in Amazon | Cyberattacks are new fear 17 years after 9/11 | Firm outs alleged British Airways hackers | Trump to target election interference with sanctions | Apple creating portal for police data requests MORE (D-Md.) wrote a letter to Oversight Chairman Trey GowdyHarold (Trey) Watson GowdyRosenstein report gives GOP new ammo against DOJ Gowdy: Declassified documents unlikely to change anyone's mind on Russia investigation Sunday shows preview: Trump sells U.N. reorganizing and Kavanaugh allegations dominate MORE (R-S.C.) on Friday urging him to request the briefing from presidential counselor Kellyanne ConwayKellyanne Elizabeth ConwayTrump Jr. to Dem Senator: 'You admitted to hitting your wife so hard it gave her a black eye!' Conway to CNN's Cuomo in heated debate: 'I'll walk away' if you continue to interrupt me On The Money: Cohen reportedly questioned over Trump dealings with Russia | Trump hails economy | Tells workers to 'start looking' if they want a better job | Internal poll shows tax law backfiring on GOP MORE, who has helmed the White House's efforts to combat the opioid epidemic.

“I understand that President TrumpDonald John TrumpGrassley: Dems 'withheld information' on new Kavanaugh allegation Health advocates decry funding transfer over migrant children Groups plan mass walkout in support of Kavanaugh accuser MORE has designated Kellyanne Conway as his point person on this issue, so her input would help the Committee with its ongoing efforts to evaluate the status of the Commission’s recommendations,” Cummings wrote.


Cummings expressed frustration at a prior effort to request a briefing from the White House, alleging that Gowdy’s staff declined to help make the request. Cummings also claimed that Gowdy requested a briefing from the Office of National Drug Control Policy (ONDCP) but that the letter was sent without asking Cummings to join.

Though committee staff from both parties met with ONDCP earlier this week, Cummings wrote that it was vital to also secure a briefing with the administration to hear about its efforts to implement the opioid commission's nearly 60 recommendations on how to combat the epidemic plaguing the U.S. Those recommendations were issued on Nov. 1.

“One problem with speaking only with ONDCP is that President Trump and his top advisors have been trying to decimate ONDCP since the first days of his Administration,” Cummings noted.

A spokesperson for Gowdy did not immediately return a request for comment.

The Office of Management and Budget was weighing proposing to nearly eliminate ONDCP in the president’s budget last year. The plan wasn’t ultimately included, as it received backlash from lawmakers and advocates.

This year, the president’s budget released Monday proposes major changes to ONDCP — moving two of its main grant programs out of the office and into other departments.

Additional news reports have suggested a lack of senior leadership at ONDCP, Cummings wrote. The White House appointed an acting director last week.